409 related articles for article (PubMed ID: 9284395)
1. Hemolytic uremic syndrome surveillance to monitor trends in infection with Escherichia coli O157:H7 and other shiga toxin-producing E. coli.
Mahon BE; Griffin PM; Mead PS; Tauxe RV
Emerg Infect Dis; 1997; 3(3):409-12. PubMed ID: 9284395
[No Abstract] [Full Text] [Related]
2. Clinical course and the role of shiga toxin-producing Escherichia coli infection in the hemolytic-uremic syndrome in pediatric patients, 1997-2000, in Germany and Austria: a prospective study.
Gerber A; Karch H; Allerberger F; Verweyen HM; Zimmerhackl LB
J Infect Dis; 2002 Aug; 186(4):493-500. PubMed ID: 12195376
[TBL] [Abstract][Full Text] [Related]
3. [The occurrence of Shiga toxin-producing Escherichia coli in humans and animals].
Heuvelink AE
Tijdschr Diergeneeskd; 1999 Nov; 124(22):671-8. PubMed ID: 10596399
[TBL] [Abstract][Full Text] [Related]
4. Child care-associated outbreak of Escherichia coli O157:H7 and hemolytic uremic syndrome.
Raffaelli RM; Paladini M; Hanson H; Kornstein L; Agasan A; Slavinski S; Weiss D; Fennelly GJ; Flynn JT
Pediatr Infect Dis J; 2007 Oct; 26(10):951-3. PubMed ID: 17901803
[TBL] [Abstract][Full Text] [Related]
5. The emerging clinical importance of non-O157 Shiga toxin-producing Escherichia coli.
Johnson KE; Thorpe CM; Sears CL
Clin Infect Dis; 2006 Dec; 43(12):1587-95. PubMed ID: 17109294
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial and antimotility agent use in persons with shiga toxin-producing Escherichia coli O157 infection in FoodNet Sites.
Nelson JM; Griffin PM; Jones TF; Smith KE; Scallan E
Clin Infect Dis; 2011 May; 52(9):1130-2. PubMed ID: 21467017
[TBL] [Abstract][Full Text] [Related]
7. Enterohaemorrhagic Escherichia coli.
Takeda Y
World Health Stat Q; 1997; 50(1-2):74-80. PubMed ID: 9282389
[TBL] [Abstract][Full Text] [Related]
8. [Enterohemorrhagic Escherichia coli and its infection: from 1977 to 1995].
Takede Y
Nihon Rinsho; 1997 Mar; 55(3):635-40. PubMed ID: 9086772
[TBL] [Abstract][Full Text] [Related]
9. National reporting of Shiga-like toxin (verotoxin) producing Escherichia coli infections and associated syndromes.
Commun Dis Intell; 1998 Oct; 22(10):223. PubMed ID: 9803601
[No Abstract] [Full Text] [Related]
10. A continuing assessment of risk factors for the development of Escherichia coli O157:H7-associated hemolytic uremic syndrome.
Cimolai N; Basalyga S; Mah DG; Morrison BJ; Carter JE
Clin Nephrol; 1994 Aug; 42(2):85-9. PubMed ID: 7955583
[TBL] [Abstract][Full Text] [Related]
11. Shiga toxin-producing Escherichia coli infections associated with hemolytic uremic syndrome, Italy, 1988-2000.
Tozzi AE; Caprioli A; Minelli F; Gianviti A; De Petris L; Edefonti A; Montini G; Ferretti A; De Palo T; Gaido M; Rizzoni G;
Emerg Infect Dis; 2003 Jan; 9(1):106-8. PubMed ID: 12533290
[TBL] [Abstract][Full Text] [Related]
12. The surveillance of vero cytotoxin-producing Escherichia coli O157 in Wales, 1990 to 1998.
Chalmers RM; Parry SM; Salmon RL; Smith RM; Willshaw GA; Cheasty T
Emerg Infect Dis; 1999; 5(4):566-9. PubMed ID: 10458968
[TBL] [Abstract][Full Text] [Related]
13. Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion.
Ake JA; Jelacic S; Ciol MA; Watkins SL; Murray KF; Christie DL; Klein EJ; Tarr PI
Pediatrics; 2005 Jun; 115(6):e673-80. PubMed ID: 15930195
[TBL] [Abstract][Full Text] [Related]
14. Hemolytic uremic syndrome due to shiga-like toxin producing Escherichia coli 048:H21 in South Australia.
Goldwater PN; Bettelheim KA
Emerg Infect Dis; 1995; 1(4):132-3. PubMed ID: 8903183
[No Abstract] [Full Text] [Related]
15. [The epidemiology of hemolytic uremic syndrome in Argentina. Diagnosis of the etiologic agent, reservoirs and routes of transmission].
Rivas M; Miliwebsky E; Chinen I; Deza N; Leotta GA
Medicina (B Aires); 2006; 66 Suppl 3():27-32. PubMed ID: 17354474
[TBL] [Abstract][Full Text] [Related]
16. Foodborne diseases: Shiga toxin producing E. coli (STEC).
Bower JR
Pediatr Infect Dis J; 1999 Oct; 18(10):909-10. PubMed ID: 10530589
[No Abstract] [Full Text] [Related]
17. Hemolytic uremic syndrome: an emerging health risk.
Razzaq S
Am Fam Physician; 2006 Sep; 74(6):991-6. PubMed ID: 17002034
[TBL] [Abstract][Full Text] [Related]
18. Bacterial genetic determinants of non-O157 STEC outbreaks and hemolytic-uremic syndrome after infection.
Wickham ME; Lupp C; Mascarenhas M; Vazquez A; Coombes BK; Brown NF; Coburn BA; Deng W; Puente JL; Karmali MA; Finlay BB
J Infect Dis; 2006 Sep; 194(6):819-27. PubMed ID: 16941350
[TBL] [Abstract][Full Text] [Related]
19. Surveillance of hemolytic uremic syndrome in children less than 15 years of age, a system to monitor O157 and non-O157 Shiga toxin-producing Escherichia coli infections in France, 1996-2006.
Espié E; Grimont F; Mariani-Kurkdjian P; Bouvet P; Haeghebaert S; Filliol I; Loirat C; Decludt B; Minh NN; Vaillant V; de Valk H
Pediatr Infect Dis J; 2008 Jul; 27(7):595-601. PubMed ID: 18520972
[TBL] [Abstract][Full Text] [Related]
20. Isolation of an Escherichia coli O157:H7 strain producing Shiga toxin 1 but not Shiga toxin 2 from a patient with hemolytic uremic syndrome in Korea.
Kim YB; Okuda J; Matsumoto C; Morigaki T; Asai N; Watanabe H; Nishibuchi M
FEMS Microbiol Lett; 1998 Sep; 166(1):43-8. PubMed ID: 9741083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
